Mexidol in Type 2 Diabetes
Mexidol (international nonproprietary name: ethylmethylhydroxypyridine succinate) is a drug developed in Russia that belongs to the class of antioxidants and antihypoxants. In the context of type 2 diabetes, it is not used to lower blood glucose levels, but it plays an important supportive role: its main task is to protect the nervous system and blood vessels from the destructive effects of the disease, in other words, to combat its complications.
Below is a detailed explanation of how Mexidol works, in which cases it is prescribed, and what research says about it.
Why is there a need for antioxidants in diabetes?
The main enemy of blood vessels and nerves in diabetes is oxidative stress. Due to persistently elevated blood glucose levels, an excess of free radicals is formed in the body. These molecules damage cell membranes and trigger the development of the classic complications of diabetes: neuropathy (nerve damage), encephalopathy (brain damage), retinopathy (damage to the retina), and angiopathy (vascular damage).
Mexidol interferes with this process by neutralizing free radicals and protecting cells from destruction.
Main areas of Mexidol use in type 2 diabetes
1. Protection of the nervous system (neuroprotection)
This is the most common reason for prescribing the drug to patients with diabetes.
Diabetic encephalopathy:
Patients with diabetes often experience impaired cognitive functions (memory and attention), as well as anxiety, apathy, and sleep disturbances. Studies show that adding Mexidol to therapy can improve cognitive functions, reduce anxiety and depression, and normalize sleep.
Diabetic polyneuropathy:
Mexidol helps slow the progression of peripheral nerve damage. It improves nerve impulse conduction and reduces symptoms of neuropathy such as numbness, burning sensations, and pain in the limbs. In one study, the drug had a favorable effect on the course of diabetic neuropathy, improving electromyographic indicators.
Diabetic foot syndrome:
Since neuropathy plays a key role in the development of this serious complication, protecting nerve fibers helps in comprehensive therapy aimed at preventing trophic ulcers.
2. Improvement of blood circulation and vascular protection
Mexidol has a positive effect on the rheological properties of blood (making it more fluid) and reduces platelet aggregation, thereby lowering the risk of blood clot formation. It may also contribute to lowering total cholesterol and low-density lipoproteins (“bad” cholesterol). This is important for the prevention of atherosclerosis, which develops more rapidly in patients with diabetes.
3. Kidney protection in pyelonephritis
Patients with diabetes often experience kidney infections that tend to be more severe due to tissue oxygen deficiency. A study conducted by researchers from Kazakhstan showed that adding Mexidol to the standard treatment of chronic pyelonephritis in diabetic patients improved renal blood flow and tissue oxygenation in the kidneys, which contributed to faster resolution of inflammatory symptoms.
4. Protection of the retina
According to the official instructions for the drug, Mexidol helps preserve retinal cells and optic nerve fibers in progressive neuropathy caused by chronic ischemia and hypoxia, which is relevant for the prevention of diabetic retinopathy.
Comparison with other drugs (for example, alpha-lipoic acid)
Alpha-lipoic acid (ALA) is considered a gold standard in the treatment of diabetic neuropathy. Interestingly, studies show that Mexidol and ALA have different mechanisms of action.
Mexidol significantly increases the activity of the enzyme superoxide dismutase, one of the main enzymes involved in antioxidant defense. Alpha-lipoic acid, in contrast, more effectively increases the activity of catalase and glutathione peroxidase.
This difference opens the possibility for combined use, as the drugs can complement each other.
Treatment regimens and dosages (based on clinical studies)
Mexidol is usually prescribed in treatment courses. It is important to note that the drug must be prescribed by a physician, as treatment regimens may vary.
For neurological complications:
In a study on diabetic encephalopathy, the following regimen was used: first, intravenous infusion of 500 mg per day for 14 days, followed by oral tablets of 250 mg three times daily for 60 days.
For polyneuropathy and diabetic foot syndrome:
In another study, the drug was administered intravenously at 300 mg per day for 14 days.
For pyelonephritis associated with diabetes:
A course of 200 mg per day administered intravenously for 10 days was used.
Dose selection:
Researchers note that the effectiveness of the drug may be dose-dependent. In one experiment comparing doses of 100 mg and 200 mg, the 200 mg daily dose was found to be more effective in correcting metabolic disturbances.
Contraindications and precautions
Like any medication, Mexidol has certain limitations.
Contraindications include:
Individual intolerance to the drug
Acute liver or kidney dysfunction (although its use in chronic conditions associated with diabetes may be possible under medical supervision)
Pregnancy and breastfeeding (due to insufficient research)
Childhood (safety has not been established)
Use with caution:
The drug contains sodium metabisulfite, which in rare cases may cause allergic reactions.
Conclusion
Mexidol in type 2 diabetes is an adjunctive therapy aimed at preventing and treating vascular and neurological complications. It does not replace glucose-lowering medications or dietary management, but it helps protect the brain, nerves, blood vessels, and kidneys from the harmful effects of high blood sugar.
Thanks to its antioxidant and antihypoxic effects, the drug may improve patients’ quality of life by reducing anxiety, fatigue, pain, and numbness in the legs, and it can also assist in the comprehensive treatment of associated conditions such as pyelonephritis.
This information is provided for educational purposes only. Consultation with a healthcare professional is required before using the medication.